BNTX logo

BioNTech SE (BNTX) Accounts receivable

Annual accounts receivable:

$1.52B-$859.62M(-36.07%)
December 31, 2024

Summary

  • As of today (May 23, 2025), BNTX annual accounts receivable is $1.52 billion, with the most recent change of -$859.62 million (-36.07%) on December 31, 2024.
  • During the last 3 years, BNTX annual accounts receivable has fallen by -$12.50 billion (-89.13%).
  • BNTX annual accounts receivable is now -89.13% below its all-time high of $14.02 billion, reached on December 31, 2021.

Performance

BNTX Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXbalance sheet metrics

Quarterly accounts receivable:

$1.04B-$488.04M(-32.04%)
March 1, 2025

Summary

  • As of today (May 23, 2025), BNTX quarterly accounts receivable is $1.04 billion, with the most recent change of -$488.04 million (-32.04%) on March 1, 2025.
  • Over the past year, BNTX quarterly accounts receivable has dropped by -$735.57 million (-41.54%).
  • BNTX quarterly accounts receivable is now -92.69% below its all-time high of $14.17 billion, reached on March 31, 2022.

Performance

BNTX Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

BNTX Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-36.1%-41.5%
3 y3 years-89.1%-92.7%
5 y5 years+10000.0%+9004.0%

BNTX Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-89.1%at low-92.7%+1174.2%
5 y5-year-89.1%>+9999.0%-92.7%>+9999.0%
alltimeall time-89.1%>+9999.0%-92.7%>+9999.0%

BNTX Accounts receivable History

DateAnnualQuarterly
Mar 2025
-
$1.04B(-32.0%)
Dec 2024
$1.52B(-36.1%)
$1.52B(+38.0%)
Sep 2024
-
$1.10B(+1258.2%)
Jun 2024
-
$81.25M(-95.4%)
Mar 2024
-
$1.77B(-25.7%)
Dec 2023
$2.38B(-68.9%)
$2.38B(+12.4%)
Sep 2023
-
$2.12B(-26.6%)
Jun 2023
-
$2.89B(-58.9%)
Mar 2023
-
$7.03B(-8.2%)
Dec 2022
$7.66B(-45.3%)
$7.66B(+6.7%)
Sep 2022
-
$7.18B(-33.8%)
Jun 2022
-
$10.85B(-23.5%)
Mar 2022
-
$14.17B(+1.1%)
DateAnnualQuarterly
Dec 2021
$14.02B(+6786.9%)
$14.02B(+14.0%)
Sep 2021
-
$12.30B(+46.6%)
Jun 2021
-
$8.39B(+198.9%)
Mar 2021
-
$2.81B(+1279.3%)
Dec 2020
$203.56M(+1425.4%)
$203.56M(+2318.2%)
Sep 2020
-
$8.42M(-2.5%)
Jun 2020
-
$8.64M(-24.1%)
Mar 2020
-
$11.37M(-14.8%)
Dec 2019
$13.34M(-38.4%)
$13.34M(+36.6%)
Sep 2019
-
$9.77M(-3.0%)
Jun 2019
-
$10.07M(-53.5%)
Dec 2018
$21.66M(+294.7%)
$21.66M
Dec 2017
$5.49M(+64.2%)
-
Dec 2016
$3.34M
-

FAQ

  • What is BioNTech SE annual accounts receivable?
  • What is the all time high annual accounts receivable for BioNTech SE?
  • What is BioNTech SE annual accounts receivable year-on-year change?
  • What is BioNTech SE quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for BioNTech SE?
  • What is BioNTech SE quarterly accounts receivable year-on-year change?

What is BioNTech SE annual accounts receivable?

The current annual accounts receivable of BNTX is $1.52B

What is the all time high annual accounts receivable for BioNTech SE?

BioNTech SE all-time high annual accounts receivable is $14.02B

What is BioNTech SE annual accounts receivable year-on-year change?

Over the past year, BNTX annual accounts receivable has changed by -$859.62M (-36.07%)

What is BioNTech SE quarterly accounts receivable?

The current quarterly accounts receivable of BNTX is $1.04B

What is the all time high quarterly accounts receivable for BioNTech SE?

BioNTech SE all-time high quarterly accounts receivable is $14.17B

What is BioNTech SE quarterly accounts receivable year-on-year change?

Over the past year, BNTX quarterly accounts receivable has changed by -$735.57M (-41.54%)
On this page